scispace - formally typeset
A

Ali Saeedi-Boroujeni

Researcher at Ahvaz Jundishapur University of Medical Sciences

Publications -  24
Citations -  408

Ali Saeedi-Boroujeni is an academic researcher from Ahvaz Jundishapur University of Medical Sciences. The author has contributed to research in topics: Inflammasome & Medicine. The author has an hindex of 8, co-authored 19 publications receiving 161 citations. Previous affiliations of Ali Saeedi-Boroujeni include Education and Research Network.

Papers
More filters
Journal ArticleDOI

Anti-inflammatory potential of Quercetin in COVID-19 treatment

Ali Saeedi-Boroujeni, +2 more
- 28 Jan 2021 - 
TL;DR: Quercetin is a carbohydrate-free flavonoid that is the most abundant flavonooid in vegetables and fruits and has been the most studied to determine the biological effects of flavonoids.
Journal ArticleDOI

Phytotherapy of nephrotoxicity-induced by cancer drugs: an updated review.

Saeid Heidari-Soreshjani, +3 more
- 16 Feb 2017 - 
TL;DR: Most important medicinal plants and their derivatives that are used to reduce anticancer drug-induced nephrotoxicity and anticancer drugs side effects via their antioxidant and anti-inflammatory properties are introduced.
Journal ArticleDOI

Efficacy of a Low Dose of Melatonin as an Adjunctive Therapy in Hospitalized Patients with COVID-19: A Randomized, Double-blind Clinical Trial.

Gholamreza Farnoosh, +11 more
- 01 Jan 2021 - 
TL;DR: In this article, the authors evaluated the clinical efficacy of adjuvant, use of melatonin in patients with COVID-19 in a single-center, double-blind, randomized clinical trial.
Posted ContentDOI

Efficacy of a Low Dose of Melatonin as an Adjunctive Therapy in Hospitalized Patients with COVID-19: A Randomized, Double-blind Clinical Trial

Gholamreza Farnoosh, +11 more
TL;DR: Adjuvant use of melatonin has a potential to improve clinical symptoms of COVID-19 patients and contribute to a faster return of patients to baseline health.
Journal ArticleDOI

COVID-19: A Case for Inhibiting NLRP3 Inflammasome, Suppression of Inflammation with Curcumin?

Ali Saeedi-Boroujeni, +4 more
- 01 Jan 2021 - 
TL;DR: Curcumin is the effective ingredient of turmeric, sometimes used as a painkiller in traditional medicine, which has extensive biological properties such as anti‐inflammatory and antioxidant activities and can potentially play a role in the treatment of COVID‐19 infection along with other drug regimens.